drugset / Trial / NCT01669538
Effect of Galantamine on Short-term Abstinence
Phase 2
Completed
98 enrolled
University of Pennsylvania
National Cancer Institute (NCI) · collabNational Center for Research Resources (NCRR) · collabNational Institute on Drug Abuse (NIDA) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled study to test whether a medication called galantamine (Brand Name: Razadyne) will help smokers quit and whether it reduces cognitive problems that smokers experience during a quit attempt.
Timeline
- Start
- 2012-08
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galantamine | Small molecule | 16 mg | — |